GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Knight Therapeutics Inc (TSX:GUD) » Definitions » Accumulated other comprehensive income (loss)

Knight Therapeutics (TSX:GUD) Accumulated other comprehensive income (loss) : C$48.8 Mil (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Knight Therapeutics Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Knight Therapeutics's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2024 was C$48.8 Mil.

Knight Therapeutics's quarterly Accumulated other comprehensive income (loss) declined from Sep. 2023 (C$54.7 Mil) to Dec. 2023 (C$29.8 Mil) but then increased from Dec. 2023 (C$29.8 Mil) to Mar. 2024 (C$48.8 Mil).

Knight Therapeutics's annual Accumulated other comprehensive income (loss) increased from Dec. 2021 (C$-0.4 Mil) to Dec. 2022 (C$41.3 Mil) but then declined from Dec. 2022 (C$41.3 Mil) to Dec. 2023 (C$29.8 Mil).


Knight Therapeutics Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Knight Therapeutics's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Knight Therapeutics Accumulated other comprehensive income (loss) Chart

Knight Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.41 -1.50 -0.38 41.27 29.83

Knight Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.15 47.43 54.69 29.83 48.80

Knight Therapeutics Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.


Knight Therapeutics Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Knight Therapeutics's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Knight Therapeutics (TSX:GUD) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Knight Therapeutics Inc (TSX:GUD) » Definitions » Accumulated other comprehensive income (loss)
Traded in Other Exchanges
Address
3400 De Maisonneuve West, Suite 1055, Montreal, QC, CAN, H3Z 3B8
Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing pharmaceutical products, consumer health products, and medical devices in Canada, Ltin America and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.
Executives
Sime Armoyan 10% Security Holder

Knight Therapeutics (TSX:GUD) Headlines

No Headlines